There are 500 million people around the world suffering from type 2 diabetes. From monitoring blood sugar to taking insulin, diabetic patients are forced to take on a huge responsibility in managing their health. Fractyl, led by Co-Founder and CEO Harith Rajagopalan, has set out to change the way we treat Type 2 diabetes patients—by shifting the focus from the pancreas to the gut.